Supplemental Balance Sheet Information (Details) - Schedule of Accrued Expenses and Other Current Liabilities - USD ($) |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Schedule of Accrued Expenses and Other Current Liabilities [Abstract] | ||
| Accrued personnel costs | $ 519,377 | $ 566,087 |
| Good received but unpaid | 8,066 | 78,579 |
| Accrued expenses for CFO separation agreement | 20,000 | 160,000 |
| Accrued legal fees | 107,570 | 157,670 |
| Accrued clinical trial expenses | 350,620 | |
| Accrued other | 102,472 | 154,575 |
| Total accrued expenses and other current liabilities | $ 1,108,105 | $ 1,116,911 |